Organ Transplantation Research Today is a free monthly online journal that collates and summarizes the latest research about Organ Transplantation, including details on risks, prognosis, procedure, surgery.

Volume 2 (2005), Issue 3 (March)

1. Combined rotational osteotomy and vascularized iliac bone graft for advanced osteonecrosis of the femoral head.
   J Reconstr Microsurg, 21(2): 101-5. [Abstract] [Full-text]
2. Matrix metalloproteinase-9 in bronchiolitis obliterans syndrome after lung transplantation.
   Eur Respir J, 25(3): 494-501. [Abstract] [Full-text]
3. Coronary artery vasospasm causing acute myocardial infarction in a heart transplant recipient.
   J Heart Lung Transplant, 24(3): 355-8. [Abstract] [Full-text]
4. Use of recombinant factor VII to control bleeding in a patient supported by right ventricular assist device after heart transplantation.
   J Heart Lung Transplant, 24(3): 347-9. [Abstract] [Full-text]
5. Treatment of parainfluenza virus 3 pneumonia in a cardiac transplant recipient with intravenous ribavirin and methylprednisolone.
   J Heart Lung Transplant, 24(3): 343-6. [Abstract] [Full-text]
6. Successful transplantation of an older donor heart with documented myocardial bridging: a case report.
   J Heart Lung Transplant, 24(3): 340-2. [Abstract] [Full-text]
7. Graft coronary artery disease in murine cardiac allografts: proposal to meet the need for standardized assessment.
   J Heart Lung Transplant, 24(3): 316-22. [Abstract] [Full-text]
8. Induction therapy after cardiac transplantation: a comparison of anti-thymocyte globulin and daclizumab in the prevention of acute rejection.
   J Heart Lung Transplant, 24(3): 296-302. [Abstract] [Full-text]
9. Psychomotor performance in lung transplant recipients: simple reaction time.
   J Heart Lung Transplant, 24(3): 282-8. [Abstract] [Full-text]
10. Evaluation of factors damaging the bronchial wall in lung transplantation.
    J Heart Lung Transplant, 24(3): 275-81. [Abstract] [Full-text]
11. Time course of physical reconditioning during exercise rehabilitation late after heart transplantation.
    J Heart Lung Transplant, 24(3): 270-4. [Abstract] [Full-text]
12. The case for selective re-issuance of medical certificates to allow pilots who have received a heart transplant to resume flying.
    J Heart Lung Transplant, 24(3): 259-69. [Abstract] [Full-text]
13. Injury of the coronary endothelium at implantation increases endothelial dysfunction and intimal hyperplasia after heart transplantation.
    J Heart Lung Transplant, 24(3): 251-8. [Abstract] [Full-text]
14. Expression of the FAST-1 transcription factor in coronary artery transplant vasculopathy and activated vascular smooth muscle cells.
    J Heart Lung Transplant, 24(3): 246-50. [Abstract] [Full-text]
15. Effect of platelet-rich plasma with autogenous bone graft for maxillary sinus augmentation in a rabbit model.
    J Oral Maxillofac Surg, 63(3): 370-6. [Abstract] [Full-text]
16. Reconstruction of severe anterior maxillary defects using distraction osteogenesis, bone grafts, and implants.
    J Oral Maxillofac Surg, 63(3): 291-7. [Abstract] [Full-text]
17. Arterial reconstruction with donor iliac vessels during pancreas transplantation: an intraoperative approach to arterial injury or inadequate flow.
    Clin Transplant, 19(2): 286-90. [Abstract] [Full-text]
18. Mycophenolate mofetil vs. azathioprine is associated with decreased acute rejection, late acute rejection, and risk for cardiovascular death in renal transplant recipients with pre-transplant diabetes.
    Clin Transplant, 19(2): 279-85. [Abstract] [Full-text]
19. Cytomegalovirus prophylaxis with valganciclovir in African-American renal allograft recipients based on donor/recipient serostatus.
    Clin Transplant, 19(2): 273-8. [Abstract] [Full-text]
20. Should people who commit themselves to organ donation be granted preferred status to receive organ transplants?
    Clin Transplant, 19(2): 269-72. [Abstract] [Full-text]
21. Limitations of glomerular filtration rate equations in the renal transplant patient.
    Clin Transplant, 19(2): 259-68. [Abstract] [Full-text]
22. Minimization of immunosuppression with thymoglobuline pre-treatment and HCV recurrence in liver transplantation.
    Clin Transplant, 19(2): 255-8. [Abstract] [Full-text]
23. Gastrointestinal hemorrhage due to complicated gastroduodenal ulcer disease in liver transplant patients taking sirolimus.
    Clin Transplant, 19(2): 250-4. [Abstract] [Full-text]
24. Airway cellular response to two different immunosuppressive regimens in lung transplant recipients.
    Clin Transplant, 19(2): 243-9. [Abstract] [Full-text]
25. Rapamycin in patients with chronic renal allograft dysfunction.
    Clin Transplant, 19(2): 236-42. [Abstract] [Full-text]
26. Urinary tract infections after renal transplantation: a retrospective review at two US transplant centers.
    Clin Transplant, 19(2): 230-5. [Abstract] [Full-text]
27. Basiliximab lowers the cyclosporine therapeutic threshold in the early post-kidney transplant period.
    Clin Transplant, 19(2): 225-9. [Abstract] [Full-text]
28. Late anastomotic leaks in pancreas transplant recipients - clinical characteristics and predisposing factors.
    Clin Transplant, 19(2): 220-4. [Abstract] [Full-text]
29. Outflow block secondary to stenosis of the inferior vena cava following living-donor liver transplantation?
    Clin Transplant, 19(2): 215-9. [Abstract] [Full-text]
30. Tobacco and alcohol use in lung transplant candidates and recipients.
    Clin Transplant, 19(2): 207-14. [Abstract] [Full-text]
31. Predictors of improvement in renal function after calcineurin inhibitor withdrawal for post-liver transplant renal dysfunction.
    Clin Transplant, 19(2): 193-8. [Abstract] [Full-text]
32. Hypertension, antihypertensive agents and outcomes following renal transplantation.
    Clin Transplant, 19(2): 181-92. [Abstract] [Full-text]
33. Feasibility of salvage liver transplantation for patients with recurrent hepatocellular carcinoma.
    Clin Transplant, 19(2): 175-80. [Abstract] [Full-text]
34. Effects of mycophenolate mofetil on donor-specific antibody formation in renal transplantation.
    Clin Transplant, 19(2): 168-74. [Abstract] [Full-text]
35. The effect of sirolimus on sex hormone levels of male renal transplant recipients.
    Clin Transplant, 19(2): 162-7. [Abstract] [Full-text]
36. Greater early pancreas graft loss in women compared with men after simultaneous pancreas-kidney transplantation.
    Clin Transplant, 19(2): 158-61. [Abstract] [Full-text]
37. The long-term outcome of tacrolimus in cadaveric kidney transplantation from non-heart beating donors.
    Clin Transplant, 19(2): 153-7. [Abstract] [Full-text]
38. Therapeutic drug monitoring for everolimus in kidney transplantation using 12-month exposure, efficacy, and safety data.
    Clin Transplant, 19(2): 145-52. [Abstract] [Full-text]
39. Easy-to-use, accurate and flexible individualized Bayesian limited sampling method without fixed time points for ciclosporin monitoring after liver transplantation.
    Aliment Pharmacol Ther, 21(5): 549-57. [Abstract] [Full-text]
40. Graft rejection mediated by CD4+ T cells via indirect recognition of alloantigen is associated with a dominant Th2 response.
    Eur J Immunol, 35(3): 843-51. [Abstract] [Full-text]
41. Hypercoagulability affecting early vein graft patency does not exist after off-pump coronary artery bypass.
    J Cardiothorac Vasc Anesth, 19(1): 11-8. [Abstract] [Full-text]
42. Central nervous system vasculitis secondary to parvovirus B19 infection in a pediatric renal transplant patient.
    Pediatr Nephrol, 20(4): 529-33. [Abstract] [Full-text]
43. Randomized prospective trial of early steroid withdrawal compared with low-dose steroids in renal transplant recipients using serial protocol biopsies to assess efficacy and safety.
    Surgery, 137(3): 364-71. [Abstract] [Full-text]
44. Repair of congenital heart lesions combined with lung transplantation for the treatment of severe pulmonary hypertension: a 13-year experience.
    J Thorac Cardiovasc Surg, 129(3): 661-9. [Abstract] [Full-text]
45. Remodeling of cortical bone allografts mediated by adherent rAAV-RANKL and VEGF gene therapy.
    Nat Med, 11(3): 291-7. [Abstract] [Full-text]
46. A simplified strategy for clinical management of late cytomegalovirus infection after oral ganciclovir prophylaxis in renal recipients.
    J Antimicrob Chemother, 55(3): 391-4. [Abstract] [Full-text]
47. Informed consent in renal transplantation.
    Postgrad Med J, 81(953): 188-90. [Abstract] [Full-text]
48. A safe zone for the passage of screws through the posterior tibial cortex in tibial tubercle transfer.
    Knee, 12(2): 99-101. [Abstract] [Full-text]
49. A simple way to assist placement of a bone graft into a soft tissue tunnel.
    Br J Oral Maxillofac Surg, 43(2): 188-9. [Abstract] [Full-text]
50. Quality of life and coping strategies among lung transplant candidates and their family caregivers.
    Soc Sci Med, 60(10): 2321-32. [Abstract] [Full-text]
51. Application of limited cone beam computed tomography to clinical assessment of alveolar bone grafting: a preliminary report.
    Cleft Palate Craniofac J, 42(2): 128-37. [Abstract] [Full-text]
52. The Renal Treatment Satisfaction Questionnaire (RTSQ): a measure of satisfaction with treatment for chronic kidney failure.
    Am J Kidney Dis, 45(3): 572-9. [Abstract] [Full-text]
53. Skin carcinoma arising from donor cells in a kidney transplant recipient.
    Cancer Res, 65(5): 1755-60. [Abstract] [Full-text]
54. Posttransplant symptomatic lymphocele treatment with percutaneous drainage and ethanol sclerosis: long-term follow-up.
    Clin Imaging, 29(2): 109-16. [Abstract] [Full-text]
55. Mycophenolic acid pharmacokinetics and related outcomes early after renal transplant.
    Br J Clin Pharmacol, 59(3): 271-80. [Abstract] [Full-text]
56. Liver transplantation as definitive treatment for a factor V Leiden mutation.
    J Pediatr, 146(3): 418-22. [Abstract] [Full-text]
57. Risk of hepatocellular carcinoma in liver mitochondrial respiratory chain disorders.
    J Pediatr, 146(3): 414-7. [Abstract] [Full-text]
58. Loose intra-articular body following anterior cruciate ligament reconstruction.
    Arthroscopy, 21(3): 348-50. [Abstract] [Full-text]
59. Primary stability of hamstring graft fixation with biodegradable suspension versus interference screws.
    Arthroscopy, 21(3): 266-74. [Abstract] [Full-text]
60. Liver transplantation for hepatocellular carcinoma.
    Best Pract Res Clin Gastroenterol, 19(1): 147-60. [Abstract] [Full-text]
61. Solvent-preserved, bovine cancellous bone blocks used for reconstruction of thoracolumbar fractures in minimally invasive spinal surgery-first clinical results.
    Eur Spine J, 14(2): 192-6. [Abstract] [Full-text]
62. Analytical approaches for transplant research, 2004.
    Am J Transplant, 5(4): 950-7. [Abstract] [Full-text]
63. Thoracic organ transplantation in the United States, 1994-2003.
    Am J Transplant, 5(4): 934-49. [Abstract] [Full-text]
64. Liver and intestine transplantation: summary analysis, 1994-2003.
    Am J Transplant, 5(4): 916-33. [Abstract] [Full-text]
65. Current status of kidney and pancreas transplantation in the United States, 1994-2003.
    Am J Transplant, 5(4): 904-15. [Abstract] [Full-text]
66. Pediatric transplantation, 1994-2003.
    Am J Transplant, 5(4): 887-903. [Abstract] [Full-text]
67. Transplant data: sources, collection and research considerations, 2004.
    Am J Transplant, 5(4): 850-61. [Abstract] [Full-text]
68. First experience with de novo calcineurin-inhibitor-free immunosuppression following cardiac transplantation.
    Am J Transplant, 5(4): 827-31. [Abstract] [Full-text]
69. The roles of a bioethicist on an organ transplantation service.
    Am J Transplant, 5(4): 821-6. [Abstract] [Full-text]
70. Preferential depletion of blood myeloid dendritic cells during acute cardiac allograft rejection under controlled immunosuppression.
    Am J Transplant, 5(4): 810-20. [Abstract] [Full-text]
71. A comparison of surgical outcomes and quality of life surveys in right lobe vs. left lateral segment liver donors.
    Am J Transplant, 5(4): 805-9. [Abstract] [Full-text]
72. The impact of pre-operative loco-regional therapy on outcome after liver transplantation for hepatocellular carcinoma.
    Am J Transplant, 5(4): 795-804. [Abstract] [Full-text]
73. Does additional doxorubicin chemotherapy improve outcome in patients with hepatocellular carcinoma treated by liver transplantation?
    Am J Transplant, 5(4): 788-94. [Abstract] [Full-text]
74. Successful liver and kidney transplantation from cadaveric donors with left-sided bacterial endocarditis.
    Am J Transplant, 5(4): 781-7. [Abstract] [Full-text]
75. Analysis of factors that influence survival with post-transplant lymphoproliferative disorder in renal transplant recipients: the Israel Penn International Transplant Tumor Registry experience.
    Am J Transplant, 5(4): 775-80. [Abstract] [Full-text]
76. Vascular endothelial growth factor expression and cyclosporine toxicity in renal allograft rejection.
    Am J Transplant, 5(4): 766-74. [Abstract] [Full-text]
77. The broad spectrum of quality in deceased donor kidneys.
    Am J Transplant, 5(4): 757-65. [Abstract] [Full-text]
78. Evaluation of T-cell receptor repertoires in patients with long-term renal allograft survival.
    Am J Transplant, 5(4): 746-56. [Abstract] [Full-text]
79. Retroperitoneoscopic live donor nephrectomy (RPLDN): establishment and initial experience of RPLDN at a single center.
    Am J Transplant, 5(4): 739-45. [Abstract] [Full-text]
80. Proteomic-based identification of cleaved urinary beta2-microglobulin as a potential marker for acute tubular injury in renal allografts.
    Am J Transplant, 5(4): 729-38. [Abstract] [Full-text]
81. Long-term prospective study of steroid withdrawal in kidney and heart transplant recipients.
    Am J Transplant, 5(4): 720-8. [Abstract] [Full-text]
82. Impact of MHC class II incompatibility on localization of mononuclear cell infiltrates to the bronchiolar compartment of orthotopic lung allografts.
    Am J Transplant, 5(4): 694-701. [Abstract] [Full-text]
83. Selectin blockade plus therapy with low-dose sirolimus and cyclosporin a prevent brain death-induced renal allograft dysfunction.
    Am J Transplant, 5(4): 662-70. [Abstract] [Full-text]
84. Lung transplantation: disease-specific considerations for referral.
    Chest, 127(3): 1006-16. [Abstract] [Full-text]
85. Long-term follow-up of patients with alcoholic liver disease after liver transplantation in Sweden: impact of structured management on recidivism.
    Scand J Gastroenterol, 40(2): 206-16. [Abstract] [Full-text]
86. Second hepatitis C replication compartment indicated by viral dynamics during liver transplantation.
    J Hepatol, 42(4): 491-8. [Abstract] [Full-text]
87. Liver transplantation for alcoholic liver disease.
    Clin Liver Dis, 9(1): 171-81. [Abstract] [Full-text]
88. Long-term management of alcoholic liver disease.
    Clin Liver Dis, 9(1): 135-49. [Abstract] [Full-text]
89. Personality characteristics among cardiothoracic transplant recipients.
    Gen Hosp Psychiatry, 27(2): 113-8. [Abstract] [Full-text]
90. Vascular and nonvascular complications of renal transplants: sonographic evaluation and correlation with other imaging modalities, surgery, and pathology.
    J Clin Ultrasound, 33(3): 127-39. [Abstract] [Full-text]
91. Osteochondral autogenous transplantation for an osteochondral defect of the first metatarsal head: a case report.
    J Foot Ankle Surg, 44(2): 152-5. [Abstract] [Full-text]
92. Risk factors for gingival overgrowth in patients medicated with ciclosporin in the absence of calcium channel blockers.
    J Clin Periodontol, 32(3): 273-9. [Abstract] [Full-text]
93. Review article: hepatitis C virus infection and type-2 diabetes mellitus in renal diseases and transplantation.
    Aliment Pharmacol Ther, 21(6): 623-32. [Abstract] [Full-text]
94. Life after transplantation: new transitions in quality of life and psychological distress.
    Semin Dial, 18(2): 124-31. [Abstract] [Full-text]
95. Macrophage-derived interleukin-18 in experimental renal allograft rejection.
    Nephrol Dial Transplant, 20(4): 699-706. [Abstract] [Full-text]
96. Persistent cytomegalovirus infection is associated with increased expression of TGF-beta1, PDGF-AA and ICAM-1 and arterial intimal thickening in kidney allografts.
    Nephrol Dial Transplant, 20(4): 790-6. [Abstract] [Full-text]
97. Tuberculosis in renal transplant recipients on various immunosuppressive regimens.
    Nephrol Dial Transplant, 20(4): 797-802. [Abstract] [Full-text]
98. Gender imbalance among donors in living kidney transplantation: the Norwegian experience.
    Nephrol Dial Transplant, 20(4): 783-9. [Abstract] [Full-text]
99. Antibodies against mesangial cells in a rat model of chronic renal allograft rejection.
    Nephrol Dial Transplant, 20(4): 692-8. [Abstract] [Full-text]
100. Clinical outcomes and C2 cyclosporin monitoring in maintenance renal transplant recipients: 1 year follow-up study.
     Nephrol Dial Transplant, 20(4): 803-10. [Abstract] [Full-text]
101. Papillary necrosis causing hydronephrosis in renal allograft treated by percutaneous retrieval of sloughed papilla.
     Br J Radiol, 78(928): 346-8. [Abstract] [Full-text]
102. Clinical experience with Certican (everolimus) in maintenance heart transplant patients at the Medical University of Vienna.
     J Heart Lung Transplant, 24(4): S206-9; discussion S210-1. [Abstract] [Full-text]
103. Clinical experience with Certican (everolimus) in de novo heart transplant patients at the Deutsches Herzzentrum Berlin.
     J Heart Lung Transplant, 24(4): S201-5; discussion S210-1. [Abstract] [Full-text]
104. Recommendations for use of Certican (everolimus) after heart transplantation: results from a German and Austrian Consensus Conference.
     J Heart Lung Transplant, 24(4): S196-200; discussion S210-1. [Abstract] [Full-text]
105. Prevention of cardiac allograft vasculopathy with Certican (everolimus): the Stanford University experience within the Certican Phase III clinical trial.
     J Heart Lung Transplant, 24(4): S191-5; discussion S210-1. [Abstract] [Full-text]
106. From clinical trials to clinical practice: an overview of Certican (everolimus) in heart transplantation.
     J Heart Lung Transplant, 24(4): S185-90; discussion S210-1. [Abstract] [Full-text]
107. Rosiglitazone is a safe and effective treatment option of new-onset diabetes mellitus after renal transplantation.
     Transpl Int, 18(4): 483-6. [Abstract] [Full-text]
108. A cluster of rotavirus enteritis in adult transplant recipients.
     Transpl Int, 18(4): 470-4. [Abstract] [Full-text]
109. Complete hepatic ischemia due to torsion of a large accessory liver lobe: first case to require transplantation.
     Transpl Int, 18(4): 467-9. [Abstract] [Full-text]
110. Weight gain and obesity after liver transplantation.
     Transpl Int, 18(4): 461-6. [Abstract] [Full-text]
111. Unusual post-transplantation recurrence of focal segmental glomerulosclerosis which resolved with cyclosporine but not with sirolimus.
     Transpl Int, 18(4): 458-60. [Abstract] [Full-text]
112. Long-term follow-up of double kidney transplantation using a score for evaluation of marginal donors*.
     Transpl Int, 18(4): 453-7. [Abstract] [Full-text]
113. A comparative study of resource use and costs of renal, liver and heart transplantation.
     Transpl Int, 18(4): 437-43. [Abstract] [Full-text]
114. Long-term results of a prospective randomized trial comparing tacrolimus versus cyclosporine in African-American recipients of primary cadaver renal transplant.
     Transpl Int, 18(4): 419-22. [Abstract] [Full-text]
115. Transplantation of organs is transplantations of donor DNA: fate of DNA disseminated in recipient.
     Transpl Int, 18(4): 412-8. [Abstract] [Full-text]
116. Using a radial artery as an interpositional vascular graft in a living-donor liver transplantation for hepatocellular carcinoma.
     Transpl Int, 18(4): 408-11. [Abstract] [Full-text]
117. Potential value of high-dose mizoribine as rescue therapy for ongoing acute humoral rejection.
     Transpl Int, 18(4): 401-7. [Abstract] [Full-text]
118. Maintenance of normothermia at operation room temperature of 24 degrees C in adult and pediatric patients undergoing liver transplantation.
     Transpl Int, 18(4): 396-400. [Abstract] [Full-text]
119. Is the transpulmonary pressure gradient a predictor for mortality after orthotopic cardiac transplantation?
     Transpl Int, 18(4): 390-5. [Abstract] [Full-text]
120. Influence of kidney function to the impact of acute rejection on long-term kidney transplant survival.
     Transpl Int, 18(4): 385-9. [Abstract] [Full-text]
121. Assessing the relative risk of cardiovascular disease among renal transplant patients receiving tacrolimus or cyclosporine.
     Transpl Int, 18(4): 379-84. [Abstract] [Full-text]
122. Generic cyclosporine formulations: more open questions than answers.
     Transpl Int, 18(4): 371-8. [Abstract] [Full-text]
123. Sequential analysis of tacrolimus dosing in adult lung transplant patients with ABCB1 haplotypes.
     J Clin Pharmacol, 45(4): 404-10. [Abstract] [Full-text]
124. Thyroid cancer in the renal transplant population: epidemiological study.
     ANZ J Surg, 75(3): 106-9. [Abstract] [Full-text]
125. Evaluation of platelet-rich plasma in combination with freeze-dried bone in the rabbit cranium. A pilot study.
     Clin Oral Implants Res, 16(2): 250-7. [Abstract] [Full-text]
126. Parietal bone as graft material for maxillary sinus floor elevation: structure and remodeling of the donor and of recipient sites.
     Clin Oral Implants Res, 16(2): 244-9. [Abstract] [Full-text]
127. Blood-filled spaces with and without deproteinized bone grafts in guided bone regeneration. A histomorphometric study of the rabbit skull using non-resorbable membrane.
     Clin Oral Implants Res, 16(2): 236-43. [Abstract] [Full-text]
128. Alveolar ridge augmentation with a prototype trilayer membrane and various bone grafts: a histomorphometric study in baboons.
     Clin Oral Implants Res, 16(2): 220-7. [Abstract] [Full-text]
129. A prospective clinical study of bone augmentation techniques at immediate implants.
     Clin Oral Implants Res, 16(2): 176-84. [Abstract] [Full-text]
130. Bone formation by enamel matrix proteins and xenografts: an experimental study in the rat ramus.
     Clin Oral Implants Res, 16(2): 140-6. [Abstract] [Full-text]
131. Long-term stability of autogenous bone grafts following combined application with guided bone regeneration.
     Clin Oral Implants Res, 16(2): 133-9. [Abstract] [Full-text]
132. A review of morbidity associated with bone harvest from the proximal tibial metaphysis.
     Mund Kiefer Gesichtschir, 9(2): 63-5. [Abstract] [Full-text]
133. Use of vascularized pedicle iliac bone graft combined with transtrochanteric rotational osteotomy in the treatment of avascular necrosis of the femoral head.
     Arch Orthop Trauma Surg, 125(2): 95-101. [Abstract] [Full-text]
134. Impact of donor, technical, and recipient risk factors on survival and quality of life after liver transplantation.
     Arch Surg, 140(3): 273-7. [Abstract] [Full-text]
135. Management and outcome of neonatal-onset ornithine transcarbamylase deficiency following liver transplantation at 60 days of life.
     Mol Genet Metab, 84(4): 363-6. [Abstract] [Full-text]
136. Value of plasma B-type natriuretic peptide as a marker for rejection in pediatric heart transplant recipients.
     Am J Cardiol, 95(7): 909-11. [Abstract] [Full-text]
137. The kidney bridge procedure for bilateral ureteral loss.
     Urology, 65(3): 591. [Abstract] [Full-text]
138. Safety and success of kidney transplantation and concomitant immunosuppression in HIV-positive patients.
     Kidney Int, 67(4): 1622-9. [Abstract] [Full-text]
139. BCA-1/CXCL13 expression is associated with CXCR5-positive B-cell cluster formation in acute renal transplant rejection.
     Kidney Int, 67(4): 1616-21. [Abstract] [Full-text]
140. Evaluation of pre-implantation kidney biopsies: comparison of Banff criteria to a morphometric approach.
     Kidney Int, 67(4): 1595-600. [Abstract] [Full-text]
141. Lectin-like oxidized low-density lipoprotein (LDL) receptor (LOX-1)-mediated pathway and vascular oxidative injury in older-age rat renal transplants.
     Kidney Int, 67(4): 1583-94. [Abstract] [Full-text]
142. Use of sirolimus and low-dose calcineurin inhibitor in lung transplant recipients with renal impairment: results of a controlled pilot study.
     Kidney Int, 67(4): 1471-5. [Abstract] [Full-text]
143. Living-donor lobar lung transplantation for pulmonary and abdominopelvic lymphangioleiomyomatosis.
     Thorac Cardiovasc Surg, 53(2): 125-7. [Abstract] [Full-text]
144. The importance of histology in the evaluation of pulmonary transplantation: carcinomatous lymphangitis.
     Thorac Cardiovasc Surg, 53(2): 122-3. [Abstract] [Full-text]
145. Cardiothoracic surgery after heart and heart-lung transplantation.
     Thorac Cardiovasc Surg, 53(2): 85-92. [Abstract] [Full-text]
146. Renography within 1 hour of renal transplantation: technical feasibility and clinical utility.
     Med Princ Pract, 14(2): 111-4. [Abstract] [Full-text]
147. Sociocultural issues in pediatric transplantation: a conceptual model.
     J Pediatr Psychol, 30(3): 235-46. [Abstract] [Full-text]
148. Transmission of rabies virus from an organ donor to four transplant recipients.
     N Engl J Med, 352(11): 1103-11. [Abstract] [Full-text]
149. Pre- and postoperative immunonutrition in patients undergoing liver transplantation: a pilot study of safety and efficacy.
     Clin Nutr, 24(2): 288-96. [Abstract] [Full-text]
150. Human leukocyte antigens in Japanese patients with biliary atresia: retrospective analysis of patients who underwent living donor liver transplantation.
     Hum Immunol, 66(3): 295-300. [Abstract] [Full-text]
151. Reduced immunosuppression in pediatric liver-intestine transplant recipients with CD8+CD28- T-suppressor cells.
     Hum Immunol, 66(3): 252-7. [Abstract] [Full-text]
152. Use of an allograft patch in repair of hypoplastic left heart syndrome may complicate future transplantation.
     Eur J Cardiothorac Surg, 27(4): 554-60. [Abstract] [Full-text]
153. Atorvastatin does not affect the pharmacokinetics of cyclosporine in renal transplant recipients.
     Eur J Clin Pharmacol, 61(1): 59-62. [Abstract] [Full-text]
154. Oral retinoids for the prevention of skin cancers in solid organ transplant recipients: a systematic review of randomized controlled trials.
     Br J Dermatol, 152(3): 518-23. [Abstract] [Full-text]
155. An unusual case of pyelonephritis in a pediatric renal transplant recipient.
     Pediatr Transplant, 9(2): 258-60. [Abstract] [Full-text]
156. Rapid response to rituximab in a pediatric liver transplant recipient with post-transplant lymphoproliferative disease and maintenance with sirolimus monotherapy.
     Pediatr Transplant, 9(2): 249-53. [Abstract] [Full-text]
157. Carcinoma of donor origin after liver-intestine transplantation in a child.
     Pediatr Transplant, 9(2): 244-8. [Abstract] [Full-text]
158. Bilateral lung transplant in Gauchers type-1 disease.
     Pediatr Transplant, 9(2): 239-43. [Abstract] [Full-text]
159. A prospective trial of steroid withdrawal after renal transplantation treated with cyclosporine and mizoribine in children: results obtained between 1990 and 2003.
     Pediatr Transplant, 9(2): 232-8. [Abstract] [Full-text]
160. Primary focal segmental glomerulosclerosis--long-term outcome after pediatric renal transplantation.
     Pediatr Transplant, 9(2): 226-31. [Abstract] [Full-text]
161. Risk factors for fungal infection in paediatric liver transplant recipients.
     Pediatr Transplant, 9(2): 220-5. [Abstract] [Full-text]
162. Hypogammaglobulinemia in pediatric liver transplant recipients.
     Pediatr Transplant, 9(2): 215-9. [Abstract] [Full-text]
163. The sensitized pediatric heart transplant candidate: causes, consequences, and treatment options.
     Pediatr Transplant, 9(2): 208-14. [Abstract] [Full-text]
164. Renal function outcome in pediatric liver transplant recipients.
     Pediatr Transplant, 9(2): 201-7. [Abstract] [Full-text]
165. Seroprevalence of antibodies against varicella-zoster virus and response to the varicella vaccine in pediatric renal transplant patients.
     Pediatr Transplant, 9(2): 192-6. [Abstract] [Full-text]
166. Invasive pneumococcal disease in pediatric organ transplant recipients: a high-risk population.
     Pediatr Transplant, 9(2): 183-6. [Abstract] [Full-text]
167. Improved long-term allograft function in pediatric renal transplantation with mycophenolate mofetil.
     Pediatr Transplant, 9(2): 178-82. [Abstract] [Full-text]
168. Beyond the first year after pediatric heart or heart-lung transplantation: Changes in cognitive function and behaviour.
     Pediatr Transplant, 9(2): 170-7. [Abstract] [Full-text]
169. Effect of age, ethnicity, and glucocorticoid use on tacrolimus pharmacokinetics in pediatric renal transplant patients.
     Pediatr Transplant, 9(2): 162-9. [Abstract] [Full-text]
170. Current status of ABO-incompatible kidney transplantation in children.
     Pediatr Transplant, 9(2): 148-54. [Abstract] [Full-text]
171. A combination of anergic cells' adoptive transfer and rapamycin therapy prolongs cardiac allograft survival in mice.
     Scand J Immunol, 61(3): 266-73. [Abstract] [Full-text]
172. Anti-HLA class II antibodies in kidney retransplant patients.
     Tissue Antigens, 65(4): 370-8. [Abstract] [Full-text]
173. Hepatitis C is a risk factor for death after liver retransplantation.
     Liver Transpl, 11(4): 434-40. [Abstract] [Full-text]
174. Heterotopic vs. orthotopic liver transplantation for chronic liver disease: a case-control comparison of short-term and long-term outcomes.
     Liver Transpl, 11(4): 396-401. [Abstract] [Full-text]
175. Immunosuppression and donor age with respect to severity of HCV recurrence after liver transplantation.
     Liver Transpl, 11(4): 386-95. [Abstract] [Full-text]
176. Wilson's disease in children: 37-year experience and revised King's score for liver transplantation.
     Liver Transpl, 11(4): 441-8. [Abstract] [Full-text]
177. Viral load at the time of liver transplantation and risk of hepatitis B virus recurrence.
     Liver Transpl, 11(4): 402-9. [Abstract] [Full-text]
178. Alcohol recidivism impairs long-term patient survival after orthotopic liver transplantation for alcoholic liver disease.
     Liver Transpl, 11(4): 420-6. [Abstract] [Full-text]
179. Hepatocyte expression of minichromosome maintenance protein-2 predicts fibrosis progression after transplantation for chronic hepatitis C virus: a pilot study.
     Liver Transpl, 11(4): 427-33. [Abstract] [Full-text]
180. Fatal course of parvovirus B19-associated myocarditis in a female liver transplant recipient.
     Liver Transpl, 11(4): 463-6. [Abstract] [Full-text]
181. Hepatic vein anatomy of the medial segment for living donor liver transplantation using extended right lobe graft.
     Liver Transpl, 11(4): 449-55. [Abstract] [Full-text]
182. Liver transplant in a patient with a ventriculoperitoneal shunt.
     Liver Transpl, 11(4): 467-8. [Abstract] [Full-text]
183. Prediction of fibrosis in HCV-infected liver transplant recipients with a simple noninvasive index.
     Liver Transpl, 11(4): 456-62. [Abstract] [Full-text]
184. Post-transplant lymphoproliferative disorder of the cervix.
     Gynecol Oncol, 97(1): 271-5. [Abstract] [Full-text]
185. Molecular case report: IgVH analysis in acute humoral and cellular liver allograft rejection suggests a selected accumulation of effector B cells and plasma cells.
     Virchows Arch, 446(3): 325-32. [Abstract] [Full-text]
186. Graft ischemic time and outcome of lung transplantation: a multicenter analysis.
     Am J Respir Crit Care Med, 171(7): 786-91. [Abstract] [Full-text]
187. Innate immunity influences long-term outcomes after human lung transplant.
     Am J Respir Crit Care Med, 171(7): 780-5. [Abstract] [Full-text]
188. Early selection of a new UL97 mutant with a severe defect of ganciclovir phosphorylation after valaciclovir prophylaxis and short-term ganciclovir therapy in a renal transplant recipient.
     Antimicrob Agents Chemother, 49(4): 1580-3. [Abstract] [Full-text]
189. Factors accelerating liver fibrosis progression in renal transplant patients receiving ribavirin monotherapy for chronic hepatitis C.
     J Med Virol, 76(1): 61-8. [Abstract] [Full-text]
190. Monitoring low cytomegalovirus viremia in transplanted patients by a real-time PCR on plasma.
     J Med Virol, 76(1): 76-81. [Abstract] [Full-text]
191. Evaluation of the micromechanical elastic properties of potential bone-grafting materials.
     J Biomed Mater Res B Appl Biomater, 73(1): 29-34. [Abstract] [Full-text]
192. Comparison of laparoscopic and open donor nephrectomy: a randomized controlled trial.
     BJU Int, 95(6): 851-5. [Abstract] [Full-text]
193. Functional heme oxygenase-1 promoter polymorphism in relation to heart failure and cardiac transplantation.
     J Heart Lung Transplant, 24(4): 493-7. [Abstract] [Full-text]
194. Bronchial hyperresponsiveness and the bronchiolitis obliterans syndrome after lung transplantation.
     J Heart Lung Transplant, 24(4): 489-92. [Abstract] [Full-text]
195. Cardiac transplantation in patients with iron overload cardiomyopathy.
     J Heart Lung Transplant, 24(4): 486-8. [Abstract] [Full-text]
196. Quality of life after lung transplantation: a cross-sectional study.
     J Heart Lung Transplant, 24(4): 474-80. [Abstract] [Full-text]
197. Short- and long-term outcomes of using pulmonary allograft donors with low Po2.
     J Heart Lung Transplant, 24(4): 470-3. [Abstract] [Full-text]
198. Antiproliferative effects of NKH477, a forskolin derivative, on cytokine profile in rat lung allografts.
     J Heart Lung Transplant, 24(4): 462-9. [Abstract] [Full-text]
199. Cyclosporine mitigates graft coronary artery disease in murine cardiac allografts: description and validation of a novel fully allogeneic model.
     J Heart Lung Transplant, 24(4): 446-53. [Abstract] [Full-text]
200. Cyclosporine treatment of high dose and long duration reduces the severity of graft coronary artery disease in rodent cardiac allografts.
     J Heart Lung Transplant, 24(4): 439-45. [Abstract] [Full-text]
201. Tumor necrosis factor gene polymorphism and cardiac allograft vasculopathy.
     J Heart Lung Transplant, 24(4): 433-8. [Abstract] [Full-text]
202. Matrix metalloproteinase induction in post-transplant obliterative bronchiolitis.
     J Heart Lung Transplant, 24(4): 426-32. [Abstract] [Full-text]
203. Successful use in lung transplantation of an immunosuppressive regimen aimed at reducing target blood levels of sirolimus and tacrolimus.
     J Heart Lung Transplant, 24(4): 421-5. [Abstract] [Full-text]
204. Brain natriuretic peptide levels do not correlate with acute cellular rejection in De Novo orthotopic heart transplant recipients.
     J Heart Lung Transplant, 24(4): 416-20. [Abstract] [Full-text]
205. Diagnostic validity of hepatocyte growth factor as marker for rejection in the follow-up of patients after heart transplantation.
     J Heart Lung Transplant, 24(4): 411-5. [Abstract] [Full-text]
206. Angiotensin converting enzyme insertion/deletion polymorphism does not influence postcardiac transplantation hypertension onset or progression.
     J Heart Lung Transplant, 24(4): 406-10. [Abstract] [Full-text]
207. Early mortality after cardiac transplantation: should we do better?
     J Heart Lung Transplant, 24(4): 401-5. [Abstract] [Full-text]
208. To induce or not to induce: do patients at greatest risk for fatal rejection benefit from cytolytic induction therapy?
     J Heart Lung Transplant, 24(4): 392-400. [Abstract] [Full-text]
209. Na+/H+ exchange inhibition and antioxidants lack additive protective effects after reperfusion injury in the working heterotopic rat heart isograft.
     J Heart Lung Transplant, 24(4): 386-91. [Abstract] [Full-text]
210. Follow-up of 28 HCMV seropositive renal-transplant recipients: comparison of clinical, biological and virological parameters in the groups of treated versus untreated infected patients.
     J Clin Virol, 33(1): 35-42. [Abstract] [Full-text]
211. Factors predicting long-term graft survival after kidney transplantation: multicenter study in Japan.
     World J Surg, 29(2): 249-56. [Abstract] [Full-text]
212. A clinically based discrete-event simulation of end-stage liver disease and the organ allocation process.
     Med Decis Making, 25(2): 199-209. [Abstract] [Full-text]
213. Sirolimus for Kaposi's sarcoma in renal-transplant recipients.
     N Engl J Med, 352(13): 1317-23. [Abstract] [Full-text]
214. Papillary renal cell carcinoma in allograft kidney.
     Eur Radiol, 15(4): 661-5. [Abstract] [Full-text]

© 2004-2008 Organ Transplantation Research Today. All Rights Reserved.